Product Information
LAMIVUDINE 150 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.4887 per EA under NDC 33342000109. Its NADAC has been published 320 times since Feb 12, 2020.
FDA first approved this application on May 1, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342000109
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LAMIVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA090198FDA Approved
5/1/2019
TE Code
AB
On Market Since
5/2/2019
Pharmacological Classes
Price Statistics
The NADAC for LAMIVUDINE 150 MG TABLET has been published 320 times since Feb 12, 2020, and over the history we have for it it has declined 47.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4887 per EA |
|---|---|
| All-time high | $1.2132 (Jan 13, 2021) |
| All-time low | $0.4126 (Oct 22, 2025) |
| 52-week high | $0.4887 |
| 52-week low | $0.4126 |
| Median price | $0.8475 |
| Average price | $0.7517 |
| Largest weekly change | -47.9% (Apr 17, 2024) |
| Weeks tracked | 320 |
| Tracking since | Feb 12, 2020 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LAMIVUDINE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE 150 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.4887 per EA (NDC 33342000109), effective Aug 19, 2026.
How has the price of LAMIVUDINE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMIVUDINE 150 MG TABLET has declined 47.5%. It has been tracked across 320 weekly CMS publications since Feb 12, 2020.
What are the highest and lowest recorded NADAC prices for LAMIVUDINE 150 MG TABLET?
Since Feb 12, 2020, the NADAC for LAMIVUDINE 150 MG TABLET has ranged from a low of $0.4126 (Oct 22, 2025) to a high of $1.2132 (Jan 13, 2021), with a median of $0.8475 per EA.
Are there cheaper alternatives to LAMIVUDINE 150 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMIVUDINE 150 MG TABLET, is $0.4797 per EA — about 2% below LAMIVUDINE 150 MG TABLET.
Who manufactures LAMIVUDINE 150 MG TABLET?
LAMIVUDINE 150 MG TABLET (NDC 33342000109) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.